Aprea Therapeutics
APRE
APRE
21 hedge funds and large institutions have $3.66M invested in Aprea Therapeutics in 2023 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 6 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
less ownership
Funds ownership: →
67% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 6
Holders
21
Holding in Top 10
–
Calls
$554K
Puts
–
Top Buyers
| 1 | +$49.3K | |
| 2 | +$13.5K | |
| 3 | +$612 | |
| 4 |
Creative Planning
Overland Park,
Kansas
|
+$105 |
| 5 |
JPMorgan Chase & Co
New York
|
+$17 |
Top Sellers
| 1 | -$47.2K | |
| 2 | -$25.6K | |
| 3 | -$6.58K | |
| 4 |
Morgan Stanley
New York
|
-$3.01K |
| 5 |
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
|
-$148 |